BBHC
LLY icon

Brown Brothers Harriman & Co’s Eli Lilly LLY Stock Holding History

Brown Brothers Harriman & Co’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$330M Buy
275,383
+29,784
+12% +$30.4M 1.45% 19
2026
Q1 		$226M Buy
245,599
+61,399
+33% +$62.2M 1.21% 24
2025
Q4 		$198M Buy
184,200
+2,349
+1% +$2.25M 1.08% 26
2025
Q3 		$139M Buy
181,851
+787
+0.4% +$586K 0.85% 33
2025
Q2 		$141M Buy
181,064
+62,226
+52% +$48.4M 0.91% 33
2025
Q1 		$98.1M Buy
118,838
+92,480
+351% +$77M 0.69% 34
2024
Q4 		$20.3M Buy
26,358
+4,690
+22% +$3.88M 0.14% 90
2024
Q3 		$19.2M Buy
21,668
+3,008
+16% +$2.7M 0.13% 90
2024
Q2 		$16.9M Buy
18,660
+2,599
+16% +$2.08M 0.13% 88
2024
Q1 		$12.5M Sell
16,061
-1,013
-6% -$721K 0.1% 103
2023
Q4 		$9.95M Buy
17,074
+80
+0.5% +$46.7K 0.08% 111
2023
Q3 		$9.13M Buy
16,994
+781
+5% +$402K 0.08% 101
2023
Q2 		$7.6M Buy
16,213
+193
+1% +$80.9K 0.06% 99
2023
Q1 		$5.5M Sell
16,020
-101
-0.6% -$34.1K 0.05% 105
2022
Q4 		$5.9M Sell
16,121
-305
-2% -$108K 0.05% 99
2022
Q3 		$5.31M Sell
16,426
-261
-2% -$82.7K 0.05% 102
2022
Q2 		$5.41M Sell
16,687
-3,544
-18% -$1.06M 0.05% 101
2022
Q1 		$5.79M Buy
20,231
+4,286
+27% +$1.1M 0.04% 108
2021
Q4 		$4.4M Buy
15,945
+695
+5% +$176K 0.02% 126
2021
Q3 		$3.52M Buy
15,250
+46
+0.3% +$11.4K 0.02% 133
2021
Q2 		$3.49M Sell
15,204
-3,013
-17% -$605K 0.02% 137
2021
Q1 		$3.4M Sell
18,217
-291
-2% -$56.9K 0.02% 134
2020
Q4 		$3.13M Sell
18,508
-250
-1% -$37.3K 0.02% 136
2020
Q3 		$2.78M Sell
18,758
-70
-0.4% -$10.8K 0.02% 138
2020
Q2 		$3.09M Sell
18,828
-224
-1% -$34.4K 0.02% 125
2020
Q1 		$2.64M Buy
19,052
+83
+0.4% +$11.4K 0.02% 126
2019
Q4 		$2.49M Buy
18,969
+3,321
+21% +$385K 0.02% 160
2019
Q3 		$1.75M Buy
15,648
+767
+5% +$85.4K 0.01% 175
2019
Q2 		$1.65M Buy
14,881
+754
+5% +$88.8K 0.01% 175
2019
Q1 		$1.83M Sell
14,127
-1,008
-7% -$123K 0.01% 161
2018
Q4 		$1.75M Buy
15,135
+624
+4% +$69.7K 0.01% 153
2018
Q3 		$1.56M Buy
14,511
+494
+4% +$49.4K 0.01% 167
2018
Q2 		$1.2M Sell
14,017
-1,444
-9% -$119K 0.01% 173
2018
Q1 		$1.2M Sell
15,461
-3,580
-19% -$288K 0.01% 167
2017
Q4 		$1.61M Buy
19,041
+5,233
+38% +$445K 0.01% 152
2017
Q3 		$1.18M Sell
13,808
-543
-4% -$44.5K 0.01% 162
2017
Q2 		$1.18M Sell
14,351
-800
-5% -$65.3K 0.01% 157
2017
Q1 		$1.27M Sell
15,151
-126
-0.8% -$10.1K 0.01% 156
2016
Q4 		$1.12M Sell
15,277
-450
-3% -$33.5K 0.01% 159
2016
Q3 		$1.26M Buy
15,727
+390
+3% +$31.2K 0.01% 161
2016
Q2 		$1.21M Sell
15,337
-487
-3% -$36.7K 0.01% 170
2016
Q1 		$1.14M Sell
15,824
-1,069
-6% -$80.9K 0.01% 174
2015
Q4 		$1.42M Sell
16,893
-321
-2% -$26.6K 0.01% 166
2015
Q3 		$1.44M Buy
17,214
+430
+3% +$36.3K 0.01% 164
2015
Q2 		$1.4M Sell
16,784
-4,146
-20% -$316K 0.01% 168
2015
Q1 		$1.52M Buy
20,930
+1,525
+8% +$109K 0.01% 167
2014
Q4 		$1.34M Buy
19,405
+3,355
+21% +$226K 0.01% 176
2014
Q3 		$1.04M Sell
16,050
-1,340
-8% -$84.8K ﹤0.01% 194
2014
Q2 		$1.08M Buy
17,390
+5,533
+47% +$330K ﹤0.01% 200
2014
Q1 		$698K Sell
11,857
-6,657
-36% -$372K ﹤0.01% 213
2013
Q4 		$944K Buy
18,514
+6,607
+55% +$331K ﹤0.01% 249
2013
Q3 		$599K Sell
11,907
-1,600
-12% -$83.8K ﹤0.01% 215
2013
Q2 		$663K Buy
+13,507
New +$735K ﹤0.01% 252

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brown Brothers Harriman & Co's LLY Position: Q2 2026 in Review

Brown Brothers Harriman & Co increased its Eli Lilly (LLY) stake by 12% in Q2 2026, buying an estimated $30.4M and bringing the position to 275,383 shares worth $330M. The position accounts for 1.45% of the portfolio, ranked #19.

Brown Brothers Harriman & Co first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Brown Brothers Harriman & Co held 275,383 shares of Eli Lilly worth $330M as of Q2 2026.
  • Brown Brothers Harriman & Co bought 29,784 Eli Lilly shares in Q2 2026, an estimated $30.4M.
  • Eli Lilly made up 1.45% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #19 holding.
  • Brown Brothers Harriman & Co first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.